US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.

Johnson & Johnson vaccines to be restarted in US despite rare clot risk

France is sticking to its plan to give over-55s the Johnson & Johnson vaccine suspended in the US and South Africa over rare blood clots, a government spokesman said Wednesday.

France sticks to plan to give J&J vaccine to over 55s

The moves come after European regulators said earlier this month they had found a possible link between AstraZeneca's COVID-19 vaccine and a similar rare blood clotting problem that led to a small number of deaths.

US pauses use of J&J vaccine over rare blood clots

Johnson & Johnson is in talks with India's government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The US drugs and healthcare giant's vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.

J&J says in talks with Indian government for trial of single-dose vaccine

Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company's late-stage COVID-19 vaccine trial after announcing that the large study had been paused due to an unexplained illness in one participant.

J&J says review of illness that led to pause of coronavirus vaccine trial could take days

Johnson & Johnson has temporarily halted its Covid-19 vaccine trial because one of its participants became sick. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement.

Johnson & Johnson halts COVID-19 vaccine trial as participant falls ill

Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick

Johnson & Johnson pauses Covid vaccine trial as participant falls ill

Johnson & Johnson said it is recalling around 33,000 bottles of baby powder after U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online.

J&J recalls 33,000 baby powder bottles

Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after US health regulators found trace amounts of asbestos in samples taken from a bottle purchased online.

J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample

Johnson & Johnson has resumed production of its baby powder at plants in India after government tests found no asbestos in the product, the company said on Thursday.

Johnson & Johnson resumes production of baby talc in India after tests find no asbestos

J&j, News on J&j, stories on J&j, articles on J&j, J&j stories at Wion, J&j news, J&j latest news

jj